← Back to the fund page Use your browser's print dialog and choose “Save as PDF”. A4, two pages.
InvestVerdict

Shriram ELSS Tax Saver Fund

Regular Plan · IDCW · ELSS (Tax Saving) · Scheme code 145821

Fund houseShriram Mutual Fund
CategoryELSS (Tax Saving)
Plan & optionRegular · IDCW
History7.6 years

Returns (%)

 1M3M6M1Y3Y5Y7Y10YLaunch
This scheme -0.293.800.45 2.367.547.16 10.8510.25
Nifty 500
benchmark
0.874.312.15 5.2012.4911.41 15.49
ELSS (Tax Saving)
category median
2.6213.2412.25 12.78

Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published NAV history for this scheme.

Risk

 VolatilitySharpeSortinoBetaAlphaMax fall
This scheme 16.0% 0.07 0.09 0.86 -3.60% -30.0% 89.21
Nifty 500
benchmark
17.2%0.35 0.47 -37.3%

Risk-free rate 6.5%. Beta, alpha and R² are regressed on the 83 months this scheme and its benchmark share.

Growth of ₹100 since launch

741341952562020202220242026InvestVerdict

Drawdown from peak (%)

0%-9%-19%-28%2020202220242026

Every one-year period it has lived through

WindowsWorstMedianBestPeriods that lost money
325 -18.5% 8.9% 53.2% 31%

Every one-year holding period in this scheme's history, not just the last one — the spread a real investor would have met depending only on when they started.

InvestVerdict

Shriram ELSS Tax Saver Fund

Regular Plan · IDCW

Allocation

By asset

Equity98.23%
Cash & Equivalents1.75%
Debt0.02%

By market cap

Concentration

Number of stocks72
Top 5 stocks25.23%
Top 10 stocks38.26%
Top 20 stocks56.01%
Largest holding7.30%
Largest sectorBanks 21.80%
Effective stocks40.8
Cash0.53%
InvestVerdict

Shriram ELSS Tax Saver Fund

Regular Plan · IDCW · holdings

Sector split

Banks — 21.8%IT - Software — 7.1%Healthcare Services — 6.2%Automobiles — 5.8%Petroleum Products — 5.8%Capital Markets — 4.3%Telecom - Services — 3.9%Pharmaceuticals & Biotechnology — 3.8%Construction — 3.7%Other — 37.5%Banks21.8%IT - Software7.1%Healthcare Services6.2%Automobiles5.8%Petroleum Products5.8%Capital Markets4.3%Telecom - Services3.9%Pharmaceuticals & Biotech…3.8%Construction3.7%Other37.5%
Banks21.80%
IT - Software7.13%
Healthcare Services6.19%
Automobiles5.79%
Petroleum Products5.79%
Capital Markets4.34%
Telecom - Services3.93%
Pharmaceuticals & Biotechnology3.80%
Construction3.72%
Industrial Products3.36%

A ₹10,000 monthly SIP over five years

InvestedValueGainXIRR
₹600,000 ₹694,790 ₹94,790 5.81%

XIRR, not CAGR — a SIP's money arrives over sixty months, so each instalment has been invested for a different length of time.

Not investment advice. InvestVerdict is not a SEBI-registered Investment Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past returns do not predict future ones. Generated 31 Aug 2026.